What is Regis Corp's earnings per share (EPS)?

Regis Corp (RGS) reported diluted earnings per share of $46.10 for fiscal year 2025. This represents a 20.2% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Regis Corp Financials

RGS

Source SEC Filings (10-K/10-Q) Data as of Mar 31, 2026 Currency USD FYE June

This page shows Regis Corp (RGS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 17 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI RGS FY2025 2026-05-13

Regis is showing a cost-reset turnaround, where lower overhead and debt reduction matter more than sales growth.

Reported profit is running ahead of operating profit: FY2025 net income was $123.5M while operating income was only $19.9M. A $115.5M tax benefit explains much of that gap, but cash conversion improved because operating cash flow turned positive and capex stayed just $1.3M, revealing a now low-capital-intensity model.

The operating turnaround looks cost-led: operating margin reached 9.5% in FY2025 after sitting at -23.0% in FY2021, even though revenue is still far below its earlier level. That pattern points to overhead reduction as the main mechanic, with selling and administrative costs taking a much smaller bite out of each sales dollar.

Longer-term solvency improved faster than day-to-day liquidity: debt-to-equity fell to 0.6x and equity is now positive, showing meaningful balance-sheet repair. But near-term cushion remains thin because cash was $17.0M against current liabilities of $101.7M, so the balance sheet looks stronger from a distance than it does over the next year.

Financial Health Signals

Financial Health Score 25/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Regis Corp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Regis Corp has an operating margin of 9.5%, meaning the company retains $9 of operating profit per $100 of revenue. This results in a moderate score of 46/100, indicating healthy but not exceptional operating efficiency. This is up from 1.1% the prior year.

Growth

Regis Corp's revenue grew a modest 3.5% year-over-year to $210.1M. This slow but positive growth earns a score of 18/100.

Leverage

Regis Corp has elevated debt relative to equity (D/E of 0.59), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 14/100, reflecting increased financial risk.

Liquidity

Regis Corp's current ratio of 0.50 is below the typical benchmark, resulting in a score of 5/100. This tight liquidity could limit financial flexibility if cash inflows slow.

Cash Flow

Regis Corp has a free cash flow margin of 5.9%, earning a moderate score of 35/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Regis Corp's ROE of 66.5% shows moderate profitability relative to equity, earning a score of 31/100. This is down from 160.3% the prior year.

Altman Z-Score Distress

0.70

Regis Corp scores 0.70, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

5/8

Regis Corp passes 5 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Low Quality

0.11x

For every $1 of reported earnings, Regis Corp generates $0.11 in operating cash flow ($13.7M OCF vs $123.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk

1.0x

Regis Corp earns $1.0 in operating income for every $1 of interest expense ($19.9M vs $20.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$210.1M

YoY+3.5%

5Y CAGR-20.7%

10Y CAGR-19.5%

Regis Corp generated $210.1M in revenue in fiscal year 2025. This represents an increase of 3.5% from the prior year.

EBITDA

$22.8M

YoY+312.0%

10Y CAGR-10.8%

Regis Corp's EBITDA was $22.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 312.0% from the prior year.

Net Income

$123.5M

YoY+35.7%

Regis Corp reported $123.5M in net income in fiscal year 2025. This represents an increase of 35.7% from the prior year.

EPS (Diluted)

$46.10

YoY+20.2%

Regis Corp earned $46.10 per diluted share (EPS) in fiscal year 2025. This represents an increase of 20.2% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$12.4M

YoY+615.3%

10Y CAGR-14.0%

Regis Corp generated $12.4M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 615.3% from the prior year.

Cash & Debt

$17.0M

YoY+68.5%

5Y CAGR-31.6%

10Y CAGR-22.3%

Regis Corp held $17.0M in cash against $109.7M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

YoY+6.8%

Regis Corp had 2M shares outstanding in fiscal year 2025. This represents an increase of 6.8% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

9.5%

YoY+8.4pp

5Y CAGR+31.2pp

10Y CAGR+9.3pp

Regis Corp's operating margin was 9.5% in fiscal year 2025, reflecting core business profitability. This is up 8.4 percentage points from the prior year.

Net Margin

58.8%

YoY+13.9pp

5Y CAGR+84.4pp

10Y CAGR+60.6pp

Regis Corp's net profit margin was 58.8% in fiscal year 2025, showing the share of revenue converted to profit. This is up 13.9 percentage points from the prior year.

Return on Equity

66.5%

YoY-93.8pp

5Y CAGR+202.9pp

10Y CAGR+71.9pp

Regis Corp's ROE was 66.5% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 93.8 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$1.3M

YoY+244.4%

5Y CAGR-49.0%

10Y CAGR-28.7%

Regis Corp invested $1.3M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 244.4% from the prior year.

RGS Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Revenue	$210.1M+3.5%	$203.0M-13.0%	$233.3M-15.5%	$276.0M-33.0%	$411.7M-38.5%	$669.7M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$46.8M+3.0%	$45.4M-10.6%	$50.8M-22.2%	$65.3M-32.3%	$96.4M-26.4%	$131.0M
Operating Income	$19.9M+834.3%	$2.1M-75.7%	$8.8M+130.4%	-$28.9M+69.5%	-$94.7M+34.9%	-$145.3M
Interest Expense	$20.3M-20.2%	$25.4M+14.7%	$22.1M+71.4%	$12.9M-1.9%	$13.2M+75.0%	$7.5M
Income Tax	-$115.5M-13390.7%	$869K+232.7%	-$655K-132.5%	$2.0M+137.2%	-$5.4M-17.5%	-$4.6M
Net Income	$123.5M+35.7%	$91.1M+1333.0%	-$7.4M+91.4%	-$85.9M+24.2%	-$113.3M+33.9%	-$171.4M
EPS (Diluted)	$46.10+20.2%	$38.34+1305.7%	$-3.18	$-39.40-1150.8%	$-3.15+34.0%	$-4.77

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Revenue	$52.4M-8.2%	$57.1M-3.1%	$59.0M-2.4%	$60.4M+6.0%	$57.0M+21.9%	$46.7M+1.4%	$46.1M-6.7%	$49.4M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$10.0M-2.8%	$10.3M-9.6%	$11.4M+9.8%	$10.3M-8.0%	$11.2M+0.7%	$11.2M-20.5%	$14.0M+20.6%	$11.6M
Operating Income	$5.7M-7.7%	$6.2M+4.7%	$5.9M-18.7%	$7.3M+45.1%	$5.0M-8.7%	$5.5M+157.6%	$2.1M+115.1%	-$14.2M
Interest Expense	$5.0M-4.4%	$5.3M-0.3%	$5.3M-3.7%	$5.5M+7.5%	$5.1M+4.9%	$4.8M0.0%	$4.8M-29.4%	$6.9M
Income Tax	$158K-84.2%	$1.0M+87.1%	$536K+100.5%	-$115.4M-11540500.0%	-$1K-100.7%	$136K+160.4%	-$225K-121.0%	$1.1M
Net Income	$735K+61.2%	$456K-66.4%	$1.4M-98.8%	$116.5M+46497.6%	$250K-96.7%	$7.6M+996.2%	-$853K-100.9%	$91.2M
EPS (Diluted)	$0.26+62.5%	$0.16-67.3%	$0.49	N/A	$0.08-97.0%	$2.71+852.8%	$-0.36	N/A

RGS Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Total Assets	$599.0M+12.9%	$530.5M-12.7%	$607.4M-21.0%	$769.3M-22.8%	$996.4M-25.8%	$1.3B
Current Assets	$50.5M+20.1%	$42.0M+12.9%	$37.2M-23.5%	$48.7M-43.8%	$86.7M-61.7%	$226.4M
Cash & Equivalents	$17.0M+68.5%	$10.1M+5.9%	$9.5M-44.2%	$17.0M-11.2%	$19.2M-83.1%	$113.7M
Inventory	$2.8M+242.1%	$818K-51.3%	$1.7M-45.9%	$3.1M-84.9%	$20.6M-67.0%	$62.6M
Accounts Receivable	$9.5M+0.4%	$9.4M-13.3%	$10.9M-25.1%	$14.5M-44.7%	$26.3M-15.3%	$31.0M
Goodwill	$183.4M+5.9%	$173.1M-0.4%	$173.8M-0.3%	$174.4M-24.1%	$229.6M+0.9%	$227.5M
Total Liabilities	$413.3M-12.7%	$473.7M-26.5%	$644.1M-19.5%	$800.3M-18.3%	$979.3M-19.5%	$1.2B
Current Liabilities	$101.7M-1.8%	$103.5M-18.1%	$126.3M-17.3%	$152.8M-23.0%	$198.5M-16.3%	$237.0M
Long-Term Debt	$109.7M+10.2%	$99.5M-43.7%	$176.8M-1.8%	$180.0M-3.7%	$186.9M+5.3%	$177.5M
Total Equity	$185.6M+226.9%	$56.8M+254.6%	-$36.7M-18.7%	-$31.0M-281.6%	$17.0M-86.4%	$125.7M
Retained Earnings	$102.0M+572.7%	-$21.6M+80.8%	-$112.6M-7.0%	-$105.2M-442.8%	-$19.4M-120.5%	$94.5M

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Total Assets	$556.6M-5.4%	$588.3M-0.6%	$592.1M-1.1%	$599.0M+17.2%	$511.2M-3.6%	$530.1M+4.2%	$508.9M-4.1%	$530.5M
Current Assets	$54.3M+4.3%	$52.1M+1.4%	$51.4M+1.8%	$50.5M+6.5%	$47.4M+9.1%	$43.4M+22.6%	$35.4M-15.8%	$42.0M
Cash & Equivalents	$22.9M+24.7%	$18.4M+11.0%	$16.6M-2.4%	$17.0M+27.6%	$13.3M+30.3%	$10.2M+62.9%	$6.3M-37.8%	$10.1M
Inventory	$2.5M-3.3%	$2.6M-6.7%	$2.8M-1.7%	$2.8M-3.5%	$2.9M-12.1%	$3.3M	N/A	$818K
Accounts Receivable	$9.0M-3.6%	$9.3M+1.3%	$9.2M-2.7%	$9.5M+5.5%	$9.0M+8.0%	$8.3M-8.5%	$9.1M-3.7%	$9.4M
Goodwill	$183.1M-0.2%	$183.4M+0.2%	$183.1M-0.2%	$183.4M-0.5%	$184.3M-2.5%	$189.0M+9.0%	$173.4M+0.1%	$173.1M
Total Liabilities	$367.1M-8.1%	$399.6M-1.2%	$404.6M-2.1%	$413.3M-6.6%	$442.6M-4.5%	$463.4M+2.4%	$452.5M-4.5%	$473.7M
Current Liabilities	$91.7M-6.5%	$98.1M-1.9%	$100.0M-1.7%	$101.7M+0.7%	$101.0M-6.1%	$107.5M+6.5%	$101.0M-2.5%	$103.5M
Long-Term Debt	$112.8M+1.4%	$111.2M+1.5%	$109.6M-0.1%	$109.7M-2.1%	$112.0M+0.4%	$111.5M+17.2%	$95.2M-4.4%	$99.5M
Total Equity	$189.4M+0.4%	$188.7M+0.6%	$187.6M+1.0%	$185.6M+170.4%	$68.6M+2.9%	$66.7M+18.3%	$56.4M-0.7%	$56.8M
Retained Earnings	$104.5M+0.7%	$103.8M+0.4%	$103.3M+1.3%	$102.0M+801.8%	-$14.5M+1.7%	-$14.8M+34.1%	-$22.4M-4.0%	-$21.6M

RGS Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Operating Cash Flow	$13.7M+773.7%	-$2.0M+74.1%	-$7.9M+79.6%	-$38.6M+61.3%	-$99.9M-15.6%	-$86.4M
Capital Expenditures	$1.3M+244.4%	$376K-21.8%	$481K-91.0%	$5.3M-53.7%	$11.5M-69.4%	$37.5M
Free Cash Flow	$12.4M+615.3%	-$2.4M+71.1%	-$8.4M+81.0%	-$44.0M+60.5%	-$111.4M+10.1%	-$123.9M
Investing Cash Flow	-$11.5M-805.2%	$1.6M-59.6%	$4.0M-47.7%	$7.7M+466.1%	-$2.1M-103.4%	$61.0M
Financing Cash Flow	$3.6M-57.1%	$8.4M+489.9%	-$2.1M-107.3%	$29.4M+278.3%	$7.8M-86.2%	$56.2M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	$0-100.0%	$28.2M

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Operating Cash Flow	$5.0M+199.0%	$1.7M-27.2%	$2.3M-66.2%	$6.8M+9.0%	$6.2M+190.9%	$2.1M+258.6%	-$1.3M-126.4%	$5.1M
Capital Expenditures	$216K-72.0%	$772K+95.4%	$395K-24.9%	$526K+61.8%	$325K-24.1%	$428K+2575.0%	$16K+300.0%	$4K
Free Cash Flow	$4.8M+433.8%	$891K-52.8%	$1.9M-69.7%	$6.2M+6.1%	$5.9M+244.9%	$1.7M+225.2%	-$1.4M-126.7%	$5.1M
Investing Cash Flow	-$216K+72.0%	-$772K-95.4%	-$395K+23.4%	-$516K-58.8%	-$325K+97.2%	-$11.6M-1327.7%	$941K+23625.0%	-$4K
Financing Cash Flow	-$300K-87.5%	-$160K+87.5%	-$1.3M+65.0%	-$3.6M-741.0%	-$434K-103.1%	$14.2M+318.1%	-$6.5M-168.9%	$9.4M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

RGS Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	9.5%+8.4pp	1.1%-2.7pp	3.8%+14.2pp	-10.5%+12.5pp	-23.0%-1.3pp	-21.7%
Net Margin	58.8%+13.9pp	44.9%+48.0pp	-3.2%+27.9pp	-31.1%-3.6pp	-27.5%-1.9pp	-25.6%
Return on Equity	66.5%-93.8pp	160.3%	N/A	N/A	-664.9%-528.5pp	-136.3%
Return on Assets	20.6%+3.5pp	17.2%+18.4pp	-1.2%+9.9pp	-11.2%+0.2pp	-11.4%+1.4pp	-12.8%
Current Ratio	0.50+0.1	0.41+0.1	0.29-0.0	0.32-0.1	0.44-0.5	0.96
Debt-to-Equity	0.59-1.2	1.75	N/A	N/A	10.97+9.6	1.41
FCF Margin	5.9%+7.1pp	-1.2%+2.4pp	-3.6%+12.3pp	-15.9%+11.1pp	-27.1%-8.6pp	-18.5%

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	10.9%+0.1pp	10.8%+0.8pp	10.0%-2.0pp	12.1%+3.2pp	8.8%-2.9pp	11.8%+7.1pp	4.6%+33.3pp	-28.7%
Net Margin	1.4%+0.6pp	0.8%-1.5pp	2.3%-190.6pp	192.9%+192.4pp	0.4%-15.9pp	16.4%+18.2pp	-1.8%-186.6pp	184.7%
Return on Equity	0.4%+0.1pp	0.2%-0.5pp	0.7%-62.0pp	62.8%+62.4pp	0.4%-11.1pp	11.5%+13.0pp	-1.5%-162.1pp	160.6%
Return on Assets	0.1%+0.0pp	0.1%-0.1pp	0.2%-19.2pp	19.4%+19.4pp	0.1%-1.4pp	1.4%+1.6pp	-0.2%-17.4pp	17.2%
Current Ratio	0.59+0.1	0.53+0.0	0.51+0.0	0.50+0.0	0.47+0.1	0.40+0.1	0.35-0.1	0.41
Debt-to-Equity	0.600.0	0.590.0	0.580.0	0.59-1.0	1.63-0.0	1.67-0.0	1.69-0.1	1.75
FCF Margin	9.1%+7.5pp	1.6%-1.6pp	3.2%-7.1pp	10.3%+0.0pp	10.3%+6.7pp	3.6%+6.6pp	-2.9%-13.3pp	10.3%

Note: The current ratio is below 1.0 (0.50), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Similar Companies

Medifast MED

$110.2M

E-Home Household Svc Hldgs Ltd EJH

$4.4M

YY Group Holdings YYGH

$4.0M

Medirom Healthcare Technologies Inc MRM

$7.8M

Stonemor Inc STON

$419.2M

Frequently Asked Questions

What is Regis Corp's annual revenue?

Regis Corp (RGS) reported $210.1M in total revenue for fiscal year 2025. This represents a 3.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Regis Corp's revenue growing?

Regis Corp (RGS) revenue grew by 3.5% year-over-year, from $203.0M to $210.1M in fiscal year 2025.

Is Regis Corp profitable?

Yes, Regis Corp (RGS) reported a net income of $123.5M in fiscal year 2025, with a net profit margin of 58.8%.

What is Regis Corp's EBITDA?

Regis Corp (RGS) had EBITDA of $22.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Regis Corp have?

As of fiscal year 2025, Regis Corp (RGS) had $17.0M in cash and equivalents against $109.7M in long-term debt.

What is Regis Corp's operating margin?

Regis Corp (RGS) had an operating margin of 9.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Regis Corp's net profit margin?

Regis Corp (RGS) had a net profit margin of 58.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Regis Corp's return on equity (ROE)?

Regis Corp (RGS) has a return on equity of 66.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Regis Corp's free cash flow?

Regis Corp (RGS) generated $12.4M in free cash flow during fiscal year 2025. This represents a 615.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Regis Corp's operating cash flow?

Regis Corp (RGS) generated $13.7M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Regis Corp's total assets?

Regis Corp (RGS) had $599.0M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Regis Corp's capital expenditures?

Regis Corp (RGS) invested $1.3M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Regis Corp have outstanding?

Regis Corp (RGS) had 2M shares outstanding as of fiscal year 2025.

What is Regis Corp's current ratio?

Regis Corp (RGS) had a current ratio of 0.50 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Regis Corp's debt-to-equity ratio?

Regis Corp (RGS) had a debt-to-equity ratio of 0.59 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Regis Corp's return on assets (ROA)?

Regis Corp (RGS) had a return on assets of 20.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Regis Corp's Altman Z-Score?

Regis Corp (RGS) has an Altman Z-Score of 0.70, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Regis Corp's Piotroski F-Score?

Regis Corp (RGS) has a Piotroski F-Score of 5 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Regis Corp's earnings high quality?

Regis Corp (RGS) has an earnings quality ratio of 0.11x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Regis Corp cover its interest payments?

Regis Corp (RGS) has an interest coverage ratio of 1.0x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Regis Corp?

Regis Corp (RGS) scores 25 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.